NASDAQ:ACXP | Cash Flow Statement | Acurx Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.25M
2026-03-31-$1.68M-$1.41M$3.11M
2025-12-31-$1.58M-$1.18M$2.83M
2025-09-30-$1.99M
2025-06-30-$2.25M
2025-03-31-$2.15M-$2.05M$2.99M
2024-12-31-$2.78M-$2.25M$194,547.00
2024-09-30-$2.82M
2024-06-30-$4.12M
2024-03-31-$4.38M-$3.06M$4.51M
2023-12-31-$5.11M-$4.2M$4.62M
2023-09-30-$3.11M
2023-06-30-$3.45M
2023-03-31-$2.9M-$1.93M
2022-12-31-$3.26M-$1.5M-$1.00
2022-09-30-$3.54M
2022-06-30-$2.62M
2022-03-31-$2.67M-$1.88M
2021-12-31-$2.63M-$1.5M$0.00
2021-09-30-$4.64M
2021-06-30-$4M
2021-03-31-$1.47M-$547,138.00
2020-12-31-$1.09M-$959,754.00$728,537.00
2020-09-30-$1.31M
2020-06-30-$913,360.00
2020-03-31-$1.28M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$7.97M-$6.79M$10.64M
2024-12-31-$14.1M-$10.38M$6.62M
2023-12-31-$14.58M-$9.8M$8.16M
2022-12-31-$12.09M-$7.54M$3.7M
2021-12-31-$12.75M-$5.01M$14.8M
2020-12-31-$4.6M-$3.35M$4.04M